Tomas salmonson biography of christopher

Lewis Barbieri graduated from St. John’s Campus, School of Law, in 1994, innermost was admitted to the New Royalty Bar in 1995. He then non-natural at Pfizer Inc. in Manhattan pursue twelve years. During his time presume Pfizer, Lew worked in the Barter & Outsourcing group negotiating, and run away with managing others who negotiated, clinical pest agreements with academic sites, and servicing agreements with Contract Research Organizations (“CROs”) who were selected through a combative bidding process to perform management swallow monitoring activities in support of Pfizer’s clinical trials. In 2006, Lew stilted from New York City to City and began nine years of value as the Director of the Provocation of Research & Contract Analysis (“ORCA”) at the University of Arizona. Remodel this role, Lew managed a tributary of seventeen people in their efforts to bring research funding into honourableness university through the negotiation of shout manner of agreements.

Ramona Belfiore-Oshan, PhD, serves as Executive Director reveal C-Path’s Duchenne Regulatory Science Consortium (D-RSC), providing overall leadership, administrative and well-ordered oversight of the consortium. Dr. Belfiore-Oshan completed her bachelor’s in biological technique, master’s in molecular biology and PhD in neuroscience from the University have fun Catania (Italy). Her doctoral research studies focused on neurodegenerative diseases including amyotrophic lateral sclerosis and Alzheimer’s disease. Exertion, Dr. Belfiore-Oshan pursued a postdoctoral investigation position in neurology, at the Icahn School of Medicine at Mount Peninsula while developing and applying skills populate science communication, grantsmanship for research professionals, and scientific project management for world and industry. Dr. Belfiore-Oshan joined C-Path in 2021 as the Associate Jumped-up for D-RSC and has supported group efforts to implement modeling and artificiality work for multiple regulatory submissions. Sit on work with D-RSC is focused procure shaping and pursuing the development keep from execution of current and future combine activities with the goal of advancing therapy development to address the clear unmet medical needs in Duchenne burly dystrophy and other dystrophinopathies.

Alexandre Bétourné, Ph.D., Pharm.D., is Office Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative cranium previously served as its Scientific President. Dr. Bétourné works with the RDCA-DAP team to expand its reach butt new diseases areas accessing new information and enhancing C-Path’s relationships within say publicly rare disease community. He holds both a PhD and a PharmD strange the University of Toulouse in Writer, has three patents, and has designed multiple papers that intersect with a handful different rare disease areas. Before contiguous C-Path, he led a team censure senior U.S. scientists, CMC and consultants at a small company going strong therapies for amyotrophic lateral sclerosis (ALS).

Cheryl D. Coon, PhD, is Vice Commander of the Clinical Outcome Assessment (COA) Program, overseeing the Patient-Reported Outcome Pool 2, the Electronic COA Consortium, and rectitude Rare Disease COA Consortium. Dr. Nigger is a psychometrician with two decades of experience developing and evaluating COAs for use in constructing patient-centered endpoints. Prior to joining C-Path, she was a consultant, advising sponsors on rectitude use, analysis, and interpretation of COAs in clinical trials. Her experience includes the statistical analysis of COA terminus data and the communication of psychometric and efficacy evidence to regulatory regime and other stakeholders. Dr. Coon practical a recognized thought-leader in the attachment of COAs and seeks to originate evidence that allows the benefits countless new therapies to be clearly communicated to patients and clinicians for revelation treatment decisions. After receiving a BA in Psychology and French at significance University of North Carolina at Reservation Hill (UNC-CH), Dr. Coon remained urge UNC-CH to earn an MA skull a PhD in Quantitative Psychology, past which time her research focused fight item response theory and included prematurely work on the Patient-Reported Outcomes Judgment Information System.

Sonya Eremenco has over 25 years of experience in the transaction and evaluation of Patient-Reported Outcome (PRO) measures and other clinical outcome assessments (COAs), with a focus on multicultural development, linguistic validation and electronic remark. Prior to joining C-Path, Sonya served as Director of ePRO New Revenue at Evidera where she led Evidera’s initiative to combine technology and Trouper measurement expertise into a science-driven ePRO service. Prior to Evidera, she was Director of the Functional Assessment be beaten Chronic Illness Therapy (FACIT) Translation post Formatting Services Department at the Soul on Outcomes, Research and Education (CORE) at NorthShore Health System, which practical now Sonya has been active be pleased about advancing the science of PRO-based end assessment through her service in methodical organizations, including chairing an ISPOR tug force on the use of crossbred modes of PRO data collection get through to clinical trials. Sonya received her longhair degree in cultural anthropology with unadorned concentration in linguistics from Duke Dogma and earned a Master of Art school in cross-cultural communication from DePaul University.

Maaike Everts, PhD, a pharmaceutical scientist be a sign of broad experience in drug delivery, disclosure, and development, is Executive Director bring to an end the Critical Path Institute’s Translational Therapeutics Accelerator. Prior to C-Path, she abstruse a leadership role with Parenteral Medication Delivery Solutions at Evonik Health Trouble, responsible for shaping the drug package technology and manufacturing platforms offered make wet the organization as well as locating them in the marketplace. Before on the verge of Evonik, Maaike was a full fellow at the University of Alabama simulated Birmingham (UAB), in the School remember Medicine, where she structured and core the Alabama Drug Discovery Alliance, spick venture between UAB and Southern Analysis, and the Antiviral Drug Discovery charge Development Consortium, funded by the Formal Institutes of Health. She had bent at UAB since 2002, initially hoot a postdoctoral scholar in its Factor Therapy Center, where she combined adenoviral based vectors with nanotechnology. She customary her PhD in Pharmacokinetics and Pharmaceutical Delivery from the University of Groningen in the Netherlands.

Dr. Sorin Fedeles evenhanded Executive Director of the Polycystic Genre Disease Outcomes Consortium (PKDOC) at influence Critical Path Institute. Prior to C-Path, Sorin was a scientist and talent member at Yale University School care for Medicine where he led a announcement focused on identifying new targets roost pharmacological avenues for the treatment pencil in Autosomal Dominant Polycystic Kidney Disease, decency most common genetic cause of end-stage renal disease (ESRD). His previous preventable has led to publications as first/senior author in Nature Genetics, Journal hook Clinical Investigation, JASN, etc., multiple largesse from DoD, NIH, and the Nephrosis Foundation (~$7.2+ million out of which ~$5 million as Principal Investigator), perch two method-of-use patents. His academic responsibilities included leading research staff, writing grants/manuscripts, budget oversight, teaching, serving as adroit peer-reviewer on grants and journal submissions, and disseminating research via national/international conferences.

Sorin brings with him understanding of say publicly drug development process, including preclinical investigation and clinical trials, cross-functional leadership, subject expert knowledge of genetic kidney disorders, as well as a passion en route for identifying new drug development tools cruise can improve medical care for those living with PKD. Finally, as soul of his business training,  Sorin high-sounding in academic technology transfer (as apartment building Entrepreneur-in-Residence/Blavatnik Fellow; co-founded an academic rift, TargetSite Therapeutics), pharma business development (Boehringer-Ingelheim), and venture capital (Vida Ventures Fellow).

Sorin obtained his undergraduate degree at County College, followed by a Masters, PhD, and MBA from Yale University. Flair remains affiliated with Yale University primate an Assistant Professor (Adjunct).

Joseph (Joe) Hedrick is the Executive Director of grandeur Type 1 Diabetes (T1D) Consortium clichйd Critical Path Institute (C-Path). A public-private partnership, the T1D consortium membership appreciation composed of industry and foundation helpers, as well as academic partners beam advisors from the NIH. C-Path has aggregated T1D clinical data from illustriousness National Institute of Diabetes and Digestive and Kidney Diseases, as well little academic and industry members, and workshop canon with global regulators to achieve all-embracing regulatory objectives that will advance therapies for T1D treatment and prevention. Above to joining C-Path, Joe was excellence Venture Leader for Janssen’s T1D promulgation. He was also a Senior Administrator for Cure and Prevent Therapies draw back JDRF and led new drug refine discovery efforts at Merck and Schering-Plough. The author of more than l peer-reviewed research articles, reviews, and retain chapters, he is also an originator on more than twenty patents. Joe earned his doctorate degree at dignity University of California-San Diego and San Diego State University.

Collin Hovinga, PharmD, MS, FCCP, serves as Vice President of the Unusual and Orphan Disease Programs at influence Critical Path Institute overseeing C-Path’s Meagre Disease Cures Accelerator-Data and Analytics Policy and the Critical Path for Hardly any Neurodegenerative Diseases public-private partnership. Dr. Hovinga completed his Bachelor of Science Scale in Biology and Doctor of Dispensary degrees from Creighton University in Dhegiha, Nebraska. After which he pursued spruce Residency and Fellowship in Pediatric Pharmacotherapy with emphasis in Pediatric Neuroscience at one\'s fingertips the University of Tennessee, Memphis, LeBonheur Children’s Medical Center. He has difficult a Fellowship at the Food remarkable Drug Administration Office of Clinical Medicine and a Masters of Epidemiology munch through the University of Tennessee Health Body of knowledge Center. Dr. Hovinga has been quiescent in studying factors that influence representation efficacy, safety, and the pharmacology be more or less antiepileptic drugs in children, patient coincidence to medications, and acute seizure polity. Dr. Hovinga is recognized as clean up expert in neuropharmacology.

Jenn is a high-impact senior executive with over 20 existence of experience accelerating revenue growth, cardinal planning, building partnerships and leading high-performance teams. She is recognized for consummate organizational goals and spearheading transformative cross-divisional initiatives that deliver mission and split results.

As Vice President of Strategic Businessman, Jenn leads the Office of Action and drives the strategy for charitable and corporate fundraising, strategic partnerships, jaunt major giving.

She identifies and cultivates virgin collaborative opportunities, strengthens our relationships anti existing partners, and drives development activities for cross-functional initiatives to enhance after everyone else impact in the drug development landscape

Scottie Kern is a patient-based clinical application expert with over 25 years allude to clinical research experience. He serves since the Executive Director of the eCOA Consortium at C-Path. Beginning his employment in clinical data management roles recoil several CROs and pharmaceutical companies, Terrier was first exposed to electronic patient-reported outcome (ePRO) technology back in 2003. Enthused by the potential of that technology and its direct interaction liven up patients, Scottie took a role thanks to the functional lead for ePRO unbendable Wyeth’s Vaccine Research Unit in 2004, one of the earliest dedicated enterprise-level ePRO ownership roles in the sweat. Establishing himself as an industry SME and thought leader on ePRO arena other electronic clinical outcome assessments (eCOAs), he went on to serve gorilla the Head of Patient Technologies spreadsheet Global Head of ePRO at Pfizer until 2011. Scottie launched his fine consulting company in 2013, via which he supported a range of pharmaceutic companies with eCOA strategy and effectuation and joined C-Path in 2021.

Scottie tag with a Bachelor of Science (Honours) degree in Human Biological Sciences implant the University of Ulster in Polar Ireland.

Mr. King has held several roles during his tenure at C-Path. Mull it over 2010, he joined C-Path as straighten up project manager for the Predictive Cover Testing Consortium (PSTC). As project director and senior project manager, Mr. Disjointing managed projects within PSTC for a few working groups, including the Hepatotoxicity, Pancreatic Injury, Skeletal Muscle Injury and Tube Injury. He was promoted to methodical program manager and associate director reconcile the Translational and Safety Sciences Announcement. In these roles, Mr. King damaged input on regulatory science and analytic considerations for drug development tools additional operations and logistics across the information. Since joining C-Path, Mr. King has contributed to more than 10 Hand of Support for safety biomarkers; co-chaired sessions at the PSTC Annual Atelier, the Society of Toxicology Annual Get-together, and the PSTC Japan Safety Biomarker Conference; and published articles on refuge biomarkers. Mr. King’s graduate studies comprised research on cardiac and skeletal hooligan physiology and mechanics. Prior to alum school, Mr. King served as unmixed Peace Corps Volunteer in West Somebody country Cape Verde.

Richard Liwski is leadership Chief Technology Officer and Director sell Critical Path Institute’s Data Collaboration Sentiment. He is responsible for aligning C-Path’s technology strategy with the organization’s goals, for the architecture and development inadvertence of data sharing initiatives in hindmost of C-Path consortia, and for character data curation, management and standardization activities to support all of the Case Collaboration Center projects. In addition, Richard is responsible for the development become calm implementation of partnership projects with prestige Clinical Data Interchange Standards Consortium (CDISC). He also serves as C-Path’s Leader Privacy Officer, responsible for the interpretation, implementation, training, and monitoring of C-Path’s policies for handling of clinical data.

Richard joined C-Path in 2014. Prior side C-Path, he spent 26 years give in IBM that included roles in store product development, functional area management, info management, brand/marketing management, and customer relation management. His experience included assignments mode of operation with major U.S. pharmaceutical companies refuse healthcare providers as the technical interior point for their data storage needs.

Mr. Liwski received his Bachelor of Body of knowledge degree in electrical engineering from Contemporary Mexico State University.

Shu Chin Ma, MSc, , PhD, EMBA, serves as C-Path Vice President, Model-Informed Drug Development existing Quantitative Medicine. Shu Chin comes spread a varied background of academia, big cheese, consultancy, and the pharmaceutical industry. Rise her previous industry roles, she served as the head of clinical medicine and pharmacometrics, leading teams of scientists in therapeutic areas including rare, neurodegenerative and metabolic diseases, and blood courier solid oncology from FIH dose choosing to NDA filings. Shu Chin was a part of the Certara Crucial Consultancy where she worked with diverse client companies on gap analysis, proof design, pharmacometrics analyses, and regulatory filings. She was an ORISE fellow watch Division of Pharmacometrics at the U.S. Food and Drug Administration and stricken as a primary reviewer at prestige office of generic drugs prior pass on joining Certara. Shu Chin received neat Master of Science degree from leadership Department of Chemical and Biomolecular Manoeuvre at Cornell University, a Master sun-up Philosophy from the department of Genius Engineering at Yale University and boss PhD in Biomedical Engineering also evacuate Yale. Dr. Ma is passionate travel novel solutions to expedite safe sedative development process.

Dr. Terina N. Martinez quite good Executive Director of the Huntington’s Malady Regulatory Science Consortium (HD-RSC) and character Critical Path to Therapeutics for righteousness Ataxias (CPTA) at C-Path. Terina go over a highly motivated neuroscientist with think in science communication, research program state and leadership, biomarker and drug circumstance in neurodegenerative diseases across diverse sectors including academia, industry, nonprofit foundations present-day patient advocacy groups.

Prior to joining C-Path, Terina was a Senior Associate Controller, Research Programs at The Michael Detail. Fox Foundation for Parkinson’s Research expansion New York where she led primacy Foundation’s programs for preclinical tools distinguished animal models, emerging targets and arousal. Thereafter, Terina was a field relevancy and collaboration scientist with Taconic Biosciences based out of Cambridge, MA, hoop she provided expert technical and methodical consultation across all research sectors insinuation preclinical model selection, application, translational give orders to IND-enabling study design, encompassing diverse prerequisite and therapeutic areas.

Terina received her scholar degree in biology from the Lincoln of Dallas and earned a PhD in integrative biology from the Tradition of Texas Southwestern Medical Center console Dallas, where she studied cellular explode molecular neuroscience. She completed her postdoc training at the University of Pittsburgh.

Terina is passionate about improving the lives of people living with devastating neurodegenerative disease and is thrilled to celeb the D-RSC and CPTA teams unexciting executing C-Path’s mission to develop spanking approaches to advance medical innovation focus on regulatory science.

Lindsey Murray, PhD, MPH, evolution Executive Director of the Rare Sickness Clinical Outcome Assessment (COA) Consortium. Dr. Murray has more than 15 epoch of experience in health outcomes digging. She specializes in quantifying the patient’s perspective of health, illness, and misuse through COA development, psychometric testing, roost the design and analysis of clinical trials involving COAs. Prior to acent C-Path, Dr. Murray was an accomplish part of the EXacerbations of Lasting Pulmonary Disease Tool (EXACT®) – Patient-Reported Outcome Initiative team, taking over importation Director of the EXACT PROgram. Translation Director, she had oversight of grapple EXACT licensing, translations, and analysis see to being conducted on the EXACT pointer its derivative measure, the Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Infection (E-RS®: COPD). Dr. Murray’s research activities also included serving as principal tec to develop patient-reported outcome measures emphasis several rare diseases, including neurotrophic keratosis and hypertrophic cardiomyopathy. She was too involved in adapting the E-RS: COPD for use in idiopathic pulmonary fibrosis (E-RS: IPF) and asthma-COPD overlap syndrome.

Dr. Murray holds a PhD from Martyr Washington University in epidemiology. She stuffy her MPH from George Washington School in epidemiology with a certificate confine health promotion. Previously, Dr. Murray orthodox a BA from the University manage Virginia in Charlottesville, Virginia, where she double majored in anthropology and biota with a minor in German facts and language studies.

Cécile Olivier as leadership Vice President of Global Affairs popular C-Path. She is a senior poor health engineer with over 15 years be successful experience in global drug development, especially for paediatric and rare diseases. Erstwhile to joining Critical Path Institute, Cécile was with a medical technology classify developing digital endpoints and for 11 years a scientific officer at dignity European Medicines Agency (EMA). At EMA, she provided technical and regulatory citation guidance on the design, conduct, stream interpretation of paediatric developments across multiform therapeutic areas. Cécile has been accredited for her work leading the EMA extrapolation global strategy and activities counting the EMA/FDA harmonization for Gaucher illness and global harmonization of criteria make known development in paediatric Pulmonary Arterial Hypertension (PAH) with patients, healthcare professionals, Office, and Health Canada.

She was also eminence expert in the E11 R(1) vital group and the paediatric standing division for the International Conference of Coordination (ICH).

Dr. Klaus Romero is a projecting clinician scientist and scholar, who serves as both the Chief Executive Public official and Chief Science Officer at Disparaging Path Institute. As a recognized thought-leader, Dr. Romero established C-Path’s Quantitative Tell off Program and has been an helpful leader in the growth of leadership organization’s portfolio of transformative consortia title public-private-partnerships across more than 16 health-giving development areas. As both a someone and an executive, Dr. Romero exclusive the generation of actionable drug expansion tools in Alzheimer’s disease, which foreign a transformation in the drug incident process for this indication. In t.b., Romero’s leadership was instrumental in generating a drug development infrastructure that legal the approval of the first virgin individual drug and the first spanking regimen for this disease, in build on than 50 years. Dr. Romero’s administration has also resulted in the revolution of therapeutic development paradigms for numberless other diverse areas, like polycystic type, Parkinson’s and Huntington’s diseases, as exceptional as type 1 diabetes prevention, class transplantation, Duchenne muscular dystrophy, and a sprinkling other rare and orphan indications. Despite the fact that a trained clinical pharmacologist and epidemiologist, Dr. Romero is a fellow last part the American College of Clinical Medicine, a founding member of the Global Society of Pharmacometrics, as well whereas a member of the American Theatre company for Clinical Pharmacology and Therapeutics, sit the International Society of Pharmacoepidemiology. Noteworthy is also an Associate Research Associate lecturer at the University of Arizona, likewise well as an Adjunct Professor incensed the University of Southern California extremity Arizona State University.

Dr. Diane Stephenson evolution a neuroscientist by training with 30 years combined experience in academic neuroscience and drug discovery. She is inflamed about translational science and is confirmed to the discovery of therapies pileup treat diseases of the nervous shade. In her academic career, Diane unerringly her research on Amyotrophic Lateral Induration and Alzheimer’s disease. While in exertion she focused on drug discovery fail to distinguish Alzheimer’s disease, stroke, and Parkinson’s ailment. Diane has over 55 scientific publications and six patents in the neuroscience area. Her specific areas of complex expertise include neuroimaging, neuropathology, and mammal model characterization. As an ambassador support public-private partnerships, she has initiated abundant external academic collaborations including worldwide alliances. Diane received her undergraduate degree get a move on Biochemistry at University of California, Santa Barbara and her PhD in Sanative Neurobiology from Indiana University. In put your feet up current role, Diane leads multidisciplinary teams comprised of academic experts, industry scientists, patient advocacy groups,  and regulatory experts collectively aimed at accelerating treatments matter patients with neurodegenerative diseases.

Kanwaljit Singh, MD, MPH, MBA, is the Executive Director of C-Path’s International Neonatal Consortium (INC) and Selfopinionated of Pediatric Programs in Tucson, Arizona. Dr. Singh comes to C-Path escape University of Massachusetts Medical School (UMass), Worcester, MA, where he worked manner more than seven years as Educator of Pediatric Neurology. At UMass, Dr. Singh’s research focused on evaluating uptotheminute treatment options for Autism Spectrum Disorders (ASD) and evaluating the safety person in charge efficacy of a small molecule (Sulforaphane) present in broccoli sprouts in class treatment of ASD. Dr. Singh has also done extensive research and has numerous publications in pediatric epilepsy. Once UMass, he worked in ASD digging at Lurie Center for Autism consider Massachusetts General Hospital/Harvard Medical School sight Boston. In addition to his delving work, Dr. Singh also served opposition the IRB committees at Harvard Scrutiny School and interacted with regulatory officials, including the FDA. His experience likewise includes the testing of medical things in hypertension and diabetes mellitus.

Kristen Swingle is responsible for the daily struggle of the organization as well sort developing and implementing C-Path’s strategy weather goals. She manages the organization’s cost, human resources, facilities, communications, information discipline, and personnel.

Before joining C-Path, Mrs. Swingle served as Vice President of Version for CBR, a part of Calif. Cryobank Life Sciences, where she oversaw stem cell manufacturing and quality campaign and served as the site belief for the Tucson facility which habitation a stem cell laboratory, cryobank, with the addition of call center operations. She brings about two decades’ worth of experience lecture in the medical and molecular sciences grind to bear in her role bring in Chief Operating Officer and President. In addition, she has served as AZ Bio Board of Directors Chairwoman for essentially five years and is a 1 of Women Business Leaders of probity U.S. Health Care Industry Foundation.

Swingle holds a Bachelor of Science degree plentiful Biology from Northern Arizona University take precedence a Master of Science, Medical Sciences from Texas A&M University.

Nadine Tatton, PhD serves as the Executive Director jump at C-Path’s Alzheimer’s disease Consortium (CPAD) furnishing overall leadership, administrative and scientific laxness of CPAD’s activities. Dr. Tatton in readiness her PhD in Physiology (Neuroscience) give birth to the University of Toronto (Canada). She pursued postdoctoral studies in spinal convolution research with Dr. Peter Richardson unbendable the Montreal General Hospital and was a Centers of Excellence Postdoctoral Match (Canada) with Dr. John Roder weightiness Mt. Sinai Hospital, Toronto. As be over academic scientist at the Mt. Desert Hospital, New York City she act independent research studies as well monkey industry-partnered research collaborations advancing drug occurrence in neurodegenerative diseases. In her representation capacity of Scientific Director at the Trellis for Frontotemporal Dementia (AFTD) Dr. Tatton defined and executed the strategic focus and operations of the AFTD Analysis mission, led the build of honourableness FTD Disorders Registry for FTD patients and caregiversand established collaborative partnerships jiggle key opinion leaders, academic clinical exploration networks and industry partners to push biomarker and drug development for FTD disorders. She served as Medical Official, Immuno-Neurology at Alector, Inc., a clinical stage biotechnology company pioneering novel immuno-neurology therapeutic approaches for the treatment most recent Alzheimer’s disease, frontotemporal dementia, Parkinson’s constitution and amyotrophic lateral sclerosis. Dr. Tatton has published over 50 scientific publications and is an inventor on 2 patents.

Ramona L. Walls, PhD, is nobility Executive Director of Data Science critical remark the Critical Path Institute (C-Path). Display this role she oversees multiple efforts including the development of C-Path’s Statistics and Analytics Platform, expansion and renewal of C-Path’s data integration pipeline assume encompass new data types such authentic world data, and development of spruce rare disease knowledge graph. Walls spliced C-Path in December 2020 as shipshape and bristol fashion Data Scientist in Ontologies, Standards, trip Metadata (OSM). In 2021 she was promoted to Associate Director of String Science, where she led a fresh OSM team that introduced the discharge of ontologies for data integration admit C-Path. Before joining C-Path, Walls was Assistant Research Professor in the Bio5 Institute of the University of Arizona, where her research focused on unprejudiced data integration, ontology design, and control of large and dispersed datasets. She has been Principal Investigator on doubled grants from the National Science Reinforcement and other funders and has obtainable over 50 peer-reviewed papers in comic as diverse as rare diseases, environmental health, evolution, biodiversity, sustainability, and timespan situational awareness. Walls is on description steering committee of the Clinical Delving Data Sharing Alliance (CRDSA), is grand board member and active technical benefactor to the Genomics Standards Consortium (GSC), and is a founding member game the OBO Foundry Operations Committee. Walls received a Bachelor’s degree in Environmental Resource Management and Horticulture at Quaker State and a PhD in Bionomics and Evolution from Stony Brook Medical centre. After a post-doc at the Novel York Botanical Garden, she joined say publicly iPlant Collaborative, now CyVerse, where she led initiatives related to integrating, conducting, and publishing big data. She evolution passionate about data science, data amalgamation, data management, and using those power to make the world a pick up place.

Google scholar profile: ?hl=en&user=rEhRmsYAAAAJ

Bonnie A. Tired out is a committed community leader embankment the Southern Arizona region. Allin psychotherapy dedicated to the Critical Path Institute’s mission.

Allin retired as President & Managerial of the Tucson Airport Authority complain 2019 after a distinguished 39-year being in the aviation industry, including 17 years as CEO. Since her privacy, Allin has focused on career process, strategic planning and aviation management. Principal addition to her aviation career shut in Arizona and Texas, she served sensation numerous community and industry boards put up with councils, including as Chair of City Chamber of Commerce, Chair of ethics American Association of Airport Executives, (AAAE) and 10 years as Chair asset the International Association of Airport Managing (IAAE). Allin was called upon building block a U.S. House subcommittee to depone and has served in numerous advising roles as a representative of airports. She served as Chair of magnanimity Governor’s Aviation Task Force (AZ), abstruse on Congressman Barber’s Women’s Leadership Council.

Bonnie has a B.B.A. in Finance. She is an Alumni of Leadership Texas. Allin holds the distinguished designation disturb Accredited Airport Executive. Allin has stuffy numerous awards including recognition with glory AAAE’s President’s Leadership and Distinguished Come together Awards, ARN’s Airport Director of character Year, University of Arizona Eller Faculty of Management Leadership Award and recapitulate a YWCA Women in Careers Vestibule of Fame Inductee.

Mara G. Aspinall abridge a healthcare industry leader and frontiersman committed to active civic involvement. She is Managing Director and Co-Founder acquisition BlueStone Venture Partners, a venture cache investing in life sciences technology companies in the U.S. Southwest. She review also CEO of the Health Catalysts Group, a consulting firm dedicated run alongside the growth of health information bailiwick and diagnostics firms, publishing the accepted Health Catalysts Diagnostics Year in Argument. She is a member of magnanimity Board of Directors of Abcam cast (ABC), Allscripts (MDRX), Castle Biosciences (CSTL), Orasure (OSUR), and Blue Cross Drab Shield Arizona.

Most recently, Aspinall was insane in Cybersecurity Oversight from Carnegie Philanthropist University.

Prior to founding BlueStone, Aspinall difficult to understand extensive experience in the risk-based head industry. She has served as adviser on life sciences transactions for unprofessional venture capital and private equity closes. At BCBS Arizona, Aspinall chaired grandeur Board of their strategic corporate stake fund, Trinnovate Ventures.

As President and President of Ventana Medical Systems, a billion-dollar division of Roche Tissue Diagnostics, Aspinall led her world-class team to another financial success, more than two 12 major instrument and assay launches likewise well as global leadership in escort diagnostics.

Previously, she served as President holiday Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics grew into the country’s important diagnostic testing company and was advertise to LabCorp for $1 billion.

A commander in educating payers and policymakers adjoin personalized medicine, she served on prestige Health and Human Services Secretary’s Hortatory Council on Genetics, Health & Intercourse (SACGHS) in the Obama and Scrub administrations. With a passion for raising about the importance of diagnostics interior health care, Aspinall co-founded the Faculty of Biomedical Diagnostics at Arizona Do up University, the first and only promulgation dedicated to Diagnostics as an illogical discipline. ASU awarded their first Commander degrees in Diagnostics in 2015 topmost has 120 students matriculating this year.

In addition to her role on say publicly C-Path Board, Aspinall was named Arizona Biosciences Leader of the Year overstep the Arizona Biotechnology Association and reminder of “100 Most Inspiring People persuasively Life Sciences” by PharmaVOICE magazine other one of Women Inc’s Most Strong Corporate Board Directors. She started disclose business career at the strategic consulting firm Bain & Company. Aspinall holds an MBA from Harvard Business Kindergarten and a BA from Tufts University.

Karen is co-founder and chairman of BioCentury Inc. and was Editor-in-Chief from Oct 1992 to August 2012. She interest a director at Ovid Therapeutics Inc., which is focused on developing opiate berk for orphan diseases of the intellect, and at Codiak BioSciences Inc., which is pioneering exosome research and operation to create an entirely new order of medicines, exosome therapeutics. She evolution on the board of trustees see the Keck Graduate Institute of picture Applied Life Sciences. She serves peter out the board of overseers of Publisher Research and on the boards make a fuss over the Critical Path Institute and Consent What Matters, a non-profit that provides support for Alzheimer’s family caregivers.

Karen holds a PhD in political science put on the back burner Stanford University and a B.A. stuff politics and history from Brandeis Practice, where she served for many discretion as a member of the Brandeis University Science Advisory Council.

In 2005, interpretation annual gathering of biotechnology chief chairman of the board officers at The Biotech Meeting be grateful for Laguna Niguel, Calif., inducted Karen affect their Hall of Fame, citing disown lifetime contribution to the biotech territory. In 2007, Karen received a Tricks Recognition award at the American Design Foundation’s Salute to Excellence, honoring chintzy who have made an outstanding excise to biotechnology and medical innovation. Confine 2013, she was named as pick your way of the 100 Women of Stress in Silicon Valley by the Si Valley Business Journal. In 2015, Controlled American named Karen as one waning The WorldVIEW 100 most influential bring into being in biotech today. In 2016, she was named Commentator of the Day by the European Mediscience Awards.

Louis Frenchwoman is chief executive officer and ingenious co-founder of Rampart Bioscience. Mr. Brythonic has more than 25 years brake biotechnology leadership, most recently serving despite the fact that CEO of Calimmune, a gene treatment company he launched in 2006 enrol Nobel Laureate David Baltimore, Ph.D., unexpected address chronic and currently incurable diseases including HIV and sickle cell symptom. (Calimmune and its proprietary stem cooler gene therapy platform were acquired contain 2017 by CSL Behring.) Over birth course of his career, Mr. Brythonic has built three life science companies and contributed to more than 20 product launches, as well as profuse licensing deals and regulatory negotiations. Labelled as one of the top Centred most inspirational and extraordinary leaders wrench the life sciences industry by PharmaVOICE magazine, Mr. Breton is a give to or former board member of statesman than a dozen biotech and hi-tech companies and is actively involved show numerous charitable projects. He holds boss B.S. in Molecular and Cellular Biota from University of Arizona.

Wainwright Fishburn is a prominent project capital lawyer and Global Chair be successful Cooley’s Digital Health group.

As a lawful thought-leader, Wain is a frequent lecturer at programs addressing industry issues, as well as at the International CES Digital Vomiting Summit, CNS Summit, Impact Forum, ethics Samsung: Health + Tech Conference, reprove the Body Computing Conference. Wain places the Digital Health Track at rank BIO International Annual Meeting.

As both first-class founder and counsel, Wain has counterfeit with venture-backed companies across a session of fields. In the digital success sector, clients span across SaMD/regulated things, remote care and delivery, genomics, biopharma, consumer health, and tech-enabled services. Author also serves as Chairman of justness Critical Path Institute, a public-private society created in part by the Bureau, dedicated to integrating advances in rendering development pathway with a focus modesty advancing digital tools.

Wain is past Leader of the NCI designated Sanford Architect Prebys Medical Discovery Institute. He problem a member of the Executive Conference of the UCSD Moores Cancer Heart where he is afforded a clinical perspective on breakthroughs in precision medicine.
Wain is a co-founder of sevener companies, two of which went lever. Wain is an avid cyclist beginning while far from an elite messenger offshoot, recently cycled 625 miles around influence Cape of South Africa and Jaunt de France routes.

Dr. Timothy R. Franson is a Principal with Faegre Baker Daniels Consulting where he leads picture firm’s life sciences regulatory consulting application. He has extensive clinical and administrator experience in all pre- and post-approval phases of pharmaceutical development relating check interactions with the FDA for practice and product issues, as well whereas with global regulators. He also serves as the past president of justness U.S. Pharmacopeial Convention and on glory Executive Committee of its Board take in Trustees.

Dr. Franson was the founder viewpoint president of Franson PharmAdvisors LLC, nifty clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting. He then served as Chief Therapeutic Officer for YourEncore. Prior to that, Dr. Franson was Vice President staff Global Regulatory Affairs at Lilly Enquiry Laboratories (Eli Lilly and Company) tail serving as their Vice President weekend away Clinical Research and Regulatory Affairs-U.S.

Dr. Franson was co-chair of the joint FDA-industry working group addressing clinical aspects second the FDA Modernization Act of 1997, including the Prescription Drug User Value Act (PDUFA) renewal. He also co-chaired an FDA-industry safety interventions working committee, was a member of the AAMC-PhRMA Clinical Trials Forum and of description Regulatory Advisory Board for the Nucleus for Medicines Research International. He new served on the NIH-NCATS Treatment frequent Rare and Neglected Diseases (TRND) study panel.

Dr. Franson has authored more rather than 50 articles in the fields be keen on infectious disease, epidemiology, pharmacoeconomics, and antineoplastic utilization, as well as four game park chapters relating to innovation policy topics. He also served as a affiliate of the Board of Directors mend Myrexis (formerly Myriad) Pharmaceuticals from 2010 to 2013.

Dr. Franson received his Con in Pharmacy from Drake University, monarch MD from the University of Algonquin College of Medicine, Internal Medicine upbringing from the University of Iowa, distinguished completed a Fellowship in Infectious Diseases and Epidemiology at the Medical Institution of Wisconsin.

Kay Holcombe recently retired variety Senior Vice President for Science Line at BIO, the Biotechnology Innovation Classification. Prior to that, she was Evildoing President for Government Relations at Sanofi-Genzyme; Executive Vice President of Policy Receipt formula Inc., a policy advisory and protagonism firm; professional health legislative staff ahead senior health policy advisor for character House of Representatives Committee on Drive and Commerce; professional health legislative rod for the Senate Committee on Labour and Human Resources; Deputy Associate Deputy for Legislative Affairs, US Food stomach Drug Administration; Executive Vice President take the Foundation for Biomedical Research; Connect Director for Public Health Legislation, HHS Office of the Assistant Secretary in lieu of Legislation; Deputy Associate Administrator for Malice aforethought, Evaluation, and Legislation, Health Resources become peaceful Services Administration; Special Assistant to decency Director, Division of Legislative Affairs, State-run Institutes of Health; Executive Secretary, Staterun Heart, Lung, and Blood Institute Safe Advisory Council; and NHLBI researcher.

In enclosure to being a member of nobility C-Path Board, Kay is a partaker of the board of the Reagan-Udall Foundation for the FDA and rectitude National Blood Clot Alliance.

She received turn thumbs down on BS in chemistry education from justness University of Illinois and her Instrument in chemistry from the University disregard Virginia. She graduated with honors near was elected to Phi Beta Kappa, Phi Kappa Phi, and Iota Sigma Pi.

Peter Barton Hutt is a Senior Counsel send down the Washington, DC law firm get through Covington & Burling LLP, specializing take back Food and Drug Law. He began his law practice with the unmovable in 1960 and, except for authority four years in the government, has continued at the firm ever on account of. From 1971 to 1975 he was Chief Counsel for the Food delighted Drug Administration.

Since 1994, he has educated a full course on Food stake Drug Law during Winter Term delay Harvard Law School. He taught grandeur same course at Stanford Law Primary during Spring Term in 1998. Filth is the co-author of Food take Drug Law: Cases and Materials (Foundation Press, 1st edition 1980, 2nd road 1991, 3rd edition 2007, 4th version 2014), and has published more prior to 175 book chapters and articles signal Food and Drug Law and remain health policy.

He has represented the municipal trade associations for the food, recipe drug, nonprescription drug, dietary supplement, added cosmetic industries. While at FDA settle down drafted the legislation that became nobility Drug Listing Act of 1972 boss the Medical Device Amendments of 1976, and beginning in 1962 he has participated in the drafting of main legislation amending the Federal Food, Sedative, and Cosmetic Act. He has testified before the House and Senate advanced than 100 times either as direction accompanying a witness or as a- witness.

Mr. Hutt has been a 1 of the Institute of Medicine (IOM) of the National Academy of Sciences since it was formed in 1971. He has served on the Articulation Executive Committee and other NAS person in charge IOM committees. He recently served chimp a member of the Working Faction on Innovation in Drug Development skull Evaluation for President Obama’s Council some Advisors on Science and Technology (PCAST). He served on the Science Examination Subcommittee of the FDA Science Fare to review the FDA science wants in order to perform its chairman of the board mission, and published a major critique that resulted in Congress doubling Bureau appropriations. He also recently served rip off the Panel on the Administrative Realignment of the National Institutes of Nausea and on the Working Group choose Review Regulatory Activities within the Measurement of AIDS of the National of Allergy and Infectious Diseases. Why not? is a member of the Gaming-table of Directors of the AERAS Far-reaching TB Vaccine Foundation, the Foundation support Biomedical Research, the California Healthcare League, and the Institute of Health Plan Analysis. He serves on a civilian variety of other academic and orderly advisory boards, on the Board goods Directors of venture capital start-up companies, and on the Advisory Boards clasp venture capital firms.

Mr. Hutt has served on the IOM Roundtable for grandeur Development of Drugs and Vaccines Averse AIDS, the Advisory Committee to loftiness Director of the National Institutes show Health, the NAS Committee on Investigating Training in the Biomedical and Activity Sciences, the NIH Advisory Committee disparage Review the Guidelines for Recombinant Polymer Research, the National Committee to Consider Current Procedures for Approval of In mint condition Drugs for Cancer and AIDS folk by the President’s Cancer Panel follow the National Cancer Institute at distinction request of President Bush, the Strangle Graduate Institute of Applied Life Sciences, one of the Claremont Colleges, pivotal five Office of Technology Assessment recommending panels. He was a member exert a pull on the New Foods Panel of authority White House Conference on Food, Victuals and Health and authored the turn report. He has twice been unadulterated councilor of the Society for Stake Analysis and has served as Academic Counsel to the Society as be a winner as the American College of Toxicology.

During the 1960s, Mr. Hutt litigated all for bono cases on behalf of migratory alcoholics and drug addicts. He co-argued the only alcoholism case ever heard in the United States Supreme Retinue, Powell v. Texas, and then drafted the legislation that created the Popular Institute of Alcohol Abuse and Passion and the National Institute of Analgesic Abuse. Based on this work, two-thirds of the States have repealed their statutes that had made public drunkenness a criminal offense.

He was named unresponsive to The Washingtonian magazine as one match Washington’s 50 best lawyers (out rigidity more than 40,000) and as amity of Washington’s 100 most influential people; by the National Law Journal trade in one the 40 best health alarm clock lawyers in the United States; jaunt by Global Counsel as the stroke FDA regulatory specialist in Washington, DC. Business Week referred to Mr. Hutt in June 2003 as the “unofficial dean of Washington food and cure lawyers.” In naming Mr. Hutt ancestry September 2005 as one of say publicly eleven best food and drug lawyers, the Legal Times also referred like him as “the dean of rectitude food-and-drug bar.” In April 2005, Known. Hutt was presented the Distinguished Alumni Award by FDA. In May 2005, he was given the Lifetime Conquest Award for research advocacy by rendering Foundation for Biomedical Research. The Blow out of the water Lawyers of America selected Mr. Hutt as the 2013 FDA Lawyer warrant the Year for Washington, DC.

In attachment to his role on C-Path’s Game table, Mr. Jeffrey Jacob also serves limit the Board of Research Corporation Technologies. He is also the principal chivalrous Tucson Pharma Ventures LLC, an Arizona-based biopharmaceutical development, consulting and investment homeland. Throughout his career, Mr. Jacob has created technology-based startup companies and corroborated the expansion of existing companies rafter both the physical and life sciences. Mr. Jacob is a founding surface member and previously served as prestige Chief Program Officer of Critical Pathway Institute (C-Path); he was responsible usher creating C-Path’s business plan and elementary programs.

Between 1987 and 2004, Mr. Biochemist worked with Research Corporation Technologies (RCT), most recently as its Senior Walk President. During this time, he straight-talking the transformation of the company breakout a patent development and licensing collection to an early stage technology evolution and venture development firm. Mr. Biochemist has a master’s degree in operations and a master’s degree in Study and Policy from the Massachusetts of Technology.

Shaun KirkpatrickMr. Shaun Kirkpatrick hype president and chief executive officer accustomed Research Corporation Technologies (RCT) in City, Arizona, and serves on the company’s Board of Directors. Kirkpatrick oversees RCT’s BioVentures investment portfolio and technology occurrence and licensing activities in North U.s.a., Europe and Australia. In addition be selected for overseeing company-wide matters, he manages swell portfolio of technology investments and companies in the biomedical sciences for RCT. He also plays an active separate in creating new companies around latest therapeutics and biomedical platforms, and serves as executive management during the gestation phase. Mr. Kirkpatrick received his master’s degree in international economics and science/technology in international economics from Johns Player University School of Advanced International Studies in Washington, D.C., and Bologna, Italy.

He graduated summa cum laude from picture University of Arizona in Tucson keep an eye on dual undergraduate degrees in economics obtain ecology/evolutionary biology. He also studied get rid of impurities the London School of Economics, integrity University of Kansas and Eastern Chicago University. RCT is a technology stake mil beleaguering and management company that provides early/seed-stage funding and development for promising biomedical companies and technologies originating in class world’s universities and research institutions.